We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Xcounter | LSE:XCT | London | Ordinary Share | SE0000963100 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 275.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/1/2010 08:12 | GETTING VERY EXCITED as news gets closer by the day.right off the radar here | buystock | |
07/1/2010 04:00 | another day closer just waiting on the big rns or the clever money.gl | buystock | |
06/1/2010 05:33 | MOBILE SECURITY news anyday | buystock | |
06/1/2010 04:42 | January 05, 2010 11:39 PM ETElectronic Equipment, Instruments and ComponentsOy Ajat Ltd. SnapshotPeople Company Overview Oy Ajat Ltd designs, develops, and manufactures radiation imaging devices for medical and industrial applications. Its products include dynamic imaging cameras, tube-sheet inspection cameras, scan linear TDI cameras, scan industrial radiography cameras, scan dental cameras, and MGC mini gamma cameras. The company also provides application and image processing software solutions. In addition, it offers manufacturing, wafer bumping, and flip-chip assembly services, as well as prototype design support services for substrates and products. The company was founded in 1994 and is based in Espoo, Finland. Tietotie 3 Espoo, 02150 Finland Founded in 1994 Phone: 358 4056 81865 Fax: 358 9455 90753 www.ajat.fi Key Executives Mr. Konstantinos Spartiotis Chairman and Chief Executive Officer Compensation as of Fiscal Year 2009. Key developments for Oy Ajat Ltd. Oy Ajat Ltd. Signs Seven Year Exclusive Agreement to Supply Innovative Monitoring Detectors to the Energy Industry 12/14/2009 Oy Ajat Ltd. has signed a seven year exclusive agreement to supply its X-ray detector technology to a Norwegian company specializing in industrial technology development within the energy industry (Commercial Partner). Pursuant to the agreement, AJAT will receive orders with minimum purchase values increasing each year up to and including 2015 and worth in aggregate 8.2 million. The commercial partner has the option to extend the contract by two years on three occasions up to a total of six years. AJAT and the commercial partner will work together on the development of these new detector products and other related technologies with broader applications to the energy industry. AJAT and the commercial partner have been working together and have already completed the first stage of the customized technology for detection devices. | buystock | |
06/1/2010 04:35 | MOBILE SECURITY and german government involvement and 2.8m grant announcement imminent Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the development of the detector technology as, under the current proposals, Artemis intends to provide 1.75m over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector development in return for exclusivity for the PCT technology in the Mammo CT application. Artemis has applied for a 2.8m grant from the German government (Bundesministerium für Bildung und Forschung) to fund half of the project. It is currently anticipated that the German government will announce the results of the grant application on or around 26 January 2010 | buystock | |
06/1/2010 04:07 | not long now | buystock | |
05/1/2010 15:50 | 05/01/2010 13:04:41 7.00 21,179 O 1,482.53 30/12/2009 08:11:39 7.00 21,144 O 1,480.08 14/12/2009 15:38:52 6.50 56,425 O 3,667.63 | buystock | |
05/1/2010 15:27 | jonno dont sit any longer get some | buystock | |
05/1/2010 14:57 | jonno news is days away or hours | buystock | |
05/1/2010 10:18 | 2.8m german grant | buystock | |
05/1/2010 09:15 | not much time left sources say very soon PCT Development XCounter aims to develop a PCT detector which the Directors believe is key to the provision of low radiation dose and high image quality scanning. The Company aims to develop a sustainable and simple but robust detector, which delivers high sensitivity and energy resolution, fulfilling the requirements for many X-ray imaging applications, as well as delivering a high frame rate that would allow for fast image recognition. Medical applications As announced on 2 July 2009, the Company is working with Artemis, a spinoff of the University of Erlangen's Institute of Medical Physics, under the leadership of Prof. Willi Kalender, to collaborate on the research and development of the PCT platform in the Mammo CT area for low dose 3D X-ray CT-imaging for breast cancer detection. The Directors believe that the new device which is intended to result from this collaboration may have the potential to offer more comprehensive and higher quality breast scanning facilitating earlier detection of breast cancer, the most common form of cancer found in women. Artemis and its founder, Prof. Kalender, have substantial expertise and a proven track record in CT physics, system and applications development. It intends to develop, validate, clinically test and commercialize a low-dose, high-resolution breast CT scanner using the XCounter photon counting digital direct conversion solid state detector technology. Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the development of the detector technology as, under the current proposals, Artemis intends to provide 1.75m over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector development in return for exclusivity for the PCT technology in the Mammo CT application. Artemis has applied for a 2.8m grant from the German government (Bundesministerium für Bildung und Forschung) to fund half of the project. It is currently anticipated that the German government will announce the results of the grant application on or around 26 January 2010. If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co- development agreement with Artemis in the first quarter of 2010 which will include provisions granting Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that time to enter into a supply agreement with Artemis, so as to exclusively manufacture and supply the detector components to be integrated into the completed Mammo CT device. The Directors believe that the total initial market for the complete Mammo CT systems to be 150m per annum. | buystock | |
04/1/2010 09:47 | jonno 14th jan expect more agreements 2 be announced | buystock | |
04/1/2010 04:00 | jonno1 its better posting information for peeps 2 chew over it wont stay this low for ever the german grant for 2.8m is due on or before the 26th of jan ie 5/6p alone plus artemis 1.8m we have + placing proceeds along with recent commercial agreements 20p+ for starters. | buystock | |
03/1/2010 18:08 | Hi buystock, agree it looks interesting, but do you have to relentlessly keep cutting and pasting, some dialogue may get some other people interested | jonno1 | |
03/1/2010 16:32 | http://voices.washin | buystock | |
03/1/2010 16:30 | 2.8m /5/6p a share due 26th or before 2.8m grant by german government we have 3 members on the grant commitee by the 26th jan more than the current mkt cap a sleeping giant 260p highs/funding resolved 2 instititional investers and new commercial partners subscribed for stock. It is a snapshot of the page as it appeared on 22 Dec 2009 17:28:35 GMT PCT Development XCounter aims to develop a PCT detector which the Directors believe is key to the provision of low radiation dose and high image quality scanning. The Company aims to develop a sustainable and simple but robust detector, which delivers high sensitivity and energy resolution, fulfilling the requirements for many X-ray imaging applications, as well as delivering a high frame rate that would allow for fast image recognition. Medical applications As announced on 2 July 2009, the Company is working with Artemis, a spinoff of the University of Erlangen's Institute of Medical Physics, under the leadership of Prof. Willi Kalender, to collaborate on the research and development of the PCT platform in the Mammo CT area for low dose 3D X-ray CT-imaging for breast cancer detection. The Directors believe that the new device which is intended to result from this collaboration may have the potential to offer more comprehensive and higher quality breast scanning facilitating earlier detection of breast cancer, the most common form of cancer found in women. Artemis and its founder, Prof. Kalender, have substantial expertise and a proven track record in CT physics, system and applications development. It intends to develop, validate, clinically test and commercialize a low-dose, high-resolution breast CT scanner using the XCounter photon counting digital direct conversion solid state detector technology. Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the development of the detector technology as, under the current proposals, Artemis intends to provide 1.75m over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector development in return for exclusivity for the PCT technology in the Mammo CT application. Artemis has applied for a 2.8m grant from the German government (Bundesministerium für Bildung und Forschung) to fund half of the project. It is currently anticipated that the German government will announce the results of the grant application on or around 26 January 2010. If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co- development agreement with Artemis in the first quarter of 2010 which will include provisions granting Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that time to enter into a supply agreement with Artemis, so as to exclusivel | buystock | |
03/1/2010 11:28 | watch this come 2 life this month | buystock | |
02/1/2010 15:07 | jonno1 rumours of a major government backed contracte for security xray device from xcounter ab xct/ajat | buystock | |
01/1/2010 07:01 | happy new year | buystock | |
31/12/2009 16:32 | a happy new year guys and plenty profits here in jan.gl | buystock | |
31/12/2009 11:22 | PEEPS THINK they are just a r&d company they aint they have multiple products on the mkt | buystock | |
31/12/2009 11:07 | Oy Ajat Ltd, Developer of Digital Radiation Cameras, Acquired by Swedish Company Swedish company XCounter AB, which is listed on the AIM stock exchange, has acquired almost one-half of the Finnish technology company Oy Ajat Ltd. Vendors in this transaction, in addition to Ajat's executive management, are Finnish Industry Investment Ltd, which divested all its holding in the company, and also Thomcapital Oy. Ajat develops and sells digital radiation imaging cameras for dentistry, medical applications and industrial use. Most notably, Ajat's technology has been highly successful in dental X-ray applications. The company's cameras are far more precise and faster than their market contenders and can, for example, inspect in real-time products moving on a conveyor belt. "With customers in Europe, Asia and the USA, Ajat is an excellent example of a growth company that has succeeded in globally commercialising Finnish-developed technology," says Finnish Industry Investment Ltd's Investment Manager Heli Kukko. Established in 2002, Ajat today employs 18 people. In 2008 the Espoo-based company generated net sales of over MEUR 3 and posted a profit. | buystock |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions